Initial Management of Hypertensive Emergency
Immediately admit the patient to an intensive care unit for continuous blood pressure monitoring and initiate parenteral antihypertensive therapy with a titratable intravenous agent. 1
Immediate Actions and Monitoring
- Admit to ICU for continuous monitoring of blood pressure and target organ damage 1
- Establish intravenous access, preferably via central line or large peripheral vein 2
- Initiate continuous blood pressure monitoring, ideally via intra-arterial line 3
- Assess for target organ damage including cardiac (ischemia, acute MI, pulmonary edema), neurological (encephalopathy, stroke), renal (acute renal failure), and vascular (aortic dissection) complications 1, 4
Blood Pressure Reduction Strategy
The approach differs based on whether a compelling condition exists:
For Patients WITHOUT Compelling Conditions (most cases):
- Reduce systolic blood pressure by no more than 25% within the first hour 1, 4
- Then, if stable, reduce to 160/100 mmHg within the next 2-6 hours 1, 4
- Cautiously normalize blood pressure over the following 24-48 hours 1, 4
For Patients WITH Compelling Conditions:
- Aortic dissection: Reduce SBP to <120 mmHg within the first hour, with heart rate <60 bpm 1, 4
- Severe preeclampsia/eclampsia: Maintain SBP <160 mmHg and DBP <105 mmHg 4
- Pheochromocytoma crisis: Reduce SBP to <140 mmHg during the first hour 1
First-Line Parenteral Medications
Labetalol (preferred for most hypertensive emergencies):
- Initial dose: 0.3-1.0 mg/kg (maximum 20 mg) via slow IV injection every 10 minutes 1
- Alternative: 0.4-1.0 mg/kg/hr IV infusion up to 3 mg/kg/hr, adjustable to cumulative dose of 300 mg 1
- Particularly useful for malignant hypertension, hypertensive encephalopathy, and stroke-related hypertension 4
- Provides both alpha- and beta-blockade, producing controlled blood pressure reduction without reflex tachycardia 5
Nicardipine (excellent alternative):
- Initial: 5 mg/hr, increasing every 5 minutes by 2.5 mg/hr to maximum 15 mg/hr 1
- Commonly used and should be available in emergency departments 3
- Requires dilution to 0.1 mg/mL concentration; change infusion site every 12 hours if using peripheral vein 2
Clevidipine:
- Initial: 1-2 mg/hr, doubling every 90 seconds until BP approaches target 1
- Maximum dose 32 mg/hr; maximum duration 72 hours 1
Condition-Specific First-Line Agents
- Acute coronary syndrome/unstable angina: Nitroglycerin (initial 5 mcg/min, increase by 5 mcg/min every 3-5 minutes to maximum 20 mcg/min) 1, 4
- Acute cardiogenic pulmonary edema: Nitroprusside or nitroglycerin 4
- Acute aortic dissection: Esmolol combined with nitroprusside or nitroglycerin 4
- Eclampsia/severe preeclampsia: Labetalol or nicardipine with magnesium sulfate 4
Critical Pitfalls to Avoid
- Never use oral short-acting nifedipine for hypertensive emergencies 4, 6, 7
- Avoid excessive rapid blood pressure reduction, which can precipitate cerebral, cardiac, or renal ischemia 1, 4
- Use sodium nitroprusside with extreme caution due to cyanide toxicity risk; if infusion rates ≥4-10 mcg/kg/min or duration >30 minutes, coadminister thiosulfate 1
- Avoid hydralazine, immediate-release nifedipine, and nitroglycerin as first-line agents due to unpredictable effects and adverse outcomes 6, 7
- Do not use oral therapy for hypertensive emergencies 1
- Monitor closely for postural hypotension with labetalol; patients should not move to erect position unmonitored 5
Transition to Oral Therapy
- Initiate oral antihypertensive therapy after 6-12 hours of parenteral therapy once blood pressure is stabilized 8
- When switching to oral nicardipine, administer first dose 1 hour prior to discontinuation of IV infusion 2
- Investigate potential secondary causes of hypertension after initial stabilization 4
- Ensure patient education regarding medication adherence to prevent recurrence 4, 3